Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Schäfer

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Drug Discovery Today|October 29, 2008
Failure is an option: learning from unsuccessful proof-of-concept trialsStefan Schäfer, Peter Kolkhof
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|November 19, 2014
Asilomar moments: formative framings in recombinant DNA and solar climate engineering researchStefan Schäfer, Sean Low
Archiv Der Pharmazie|July 26, 2005
Chromatin modifications as targets for new anticancer drugsStefan Schäfer, Manfred Jung
Science (New York, N.Y.)|June 1, 2019
Promises and perils of the Paris AgreementMark G Lawrence, Stefan Schäfer
Pharmazie in Unserer Zeit|February 13, 2003
[Management of high blood pressure and cardiac insufficiency. New drugs and therapeutic concepts]Stefan Schäfer, Andreas E Busch
Journal of Translational Medicine|December 5, 2006
Decreased wheel-running activity in hamsters post myocardial infarctionStefan Schäfer, Wolfgang Linz, Katja Hürland
Social Studies of Science|November 17, 2023
Governing beyond the project: Refocusing innovation governance in emerging science and technology fundingRobert Dj Smith, Stefan Schäfer, Michael J Bernstein
Journal of Cardiovascular Pharmacology|July 10, 2004
Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp ratJames C Russell, Sandra E Kelly, Stefan Schäfer
Zeitschrift Fur Geburtshilfe Und Neonatologie|February 22, 2019
Fabian Winterholler, Veronika Ernst, Stefan Schäfer, et al.
Drug Discovery Today|December 7, 2007
One target-multiple indications: a call for an integrated common mechanisms strategyUlrich Nielsch, Stefan Schäfer, Hanno Wild, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Drug Discovery Today|October 29, 2008
Failure is an option: learning from unsuccessful proof-of-concept trialsStefan Schäfer, Peter Kolkhof
Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences|November 19, 2014
Asilomar moments: formative framings in recombinant DNA and solar climate engineering researchStefan Schäfer, Sean Low
Archiv Der Pharmazie|July 26, 2005
Chromatin modifications as targets for new anticancer drugsStefan Schäfer, Manfred Jung
Science (New York, N.Y.)|June 1, 2019
Promises and perils of the Paris AgreementMark G Lawrence, Stefan Schäfer
Pharmazie in Unserer Zeit|February 13, 2003
[Management of high blood pressure and cardiac insufficiency. New drugs and therapeutic concepts]Stefan Schäfer, Andreas E Busch
Journal of Translational Medicine|December 5, 2006
Decreased wheel-running activity in hamsters post myocardial infarctionStefan Schäfer, Wolfgang Linz, Katja Hürland
Social Studies of Science|November 17, 2023
Governing beyond the project: Refocusing innovation governance in emerging science and technology fundingRobert Dj Smith, Stefan Schäfer, Michael J Bernstein
Journal of Cardiovascular Pharmacology|July 10, 2004
Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp ratJames C Russell, Sandra E Kelly, Stefan Schäfer
Zeitschrift Fur Geburtshilfe Und Neonatologie|February 22, 2019
Fabian Winterholler, Veronika Ernst, Stefan Schäfer, et al.
Drug Discovery Today|December 7, 2007
One target-multiple indications: a call for an integrated common mechanisms strategyUlrich Nielsch, Stefan Schäfer, Hanno Wild, et al.
Pageof 5